SCHEMBL24251327

SCHEMBL24251327

c1ccc(-c2cccc(N(c3ccc(-c4c(-c5ccccc5)cccc4-c4ccccc4)cc3)c3ccc4ccc5c(N(c6ccc(-c7c(-c8ccccc8)cccc7-c7ccccc7)cc6)c6cccc(-c7ccccc7)c6)ccc6ccc3c4c65)c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
HSD17B1 P14061 2/20 0.34
HSD17B2 P37059 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2B6 P20813 1/20 0.34
CYP2C19 P33261 1/20 0.34
CDK4 P11802 6/20 0.32
CCND1 P24385 6/20 0.32
IMPDH2 P12268 1/20 0.31
DHFR P00374 1/20 0.31
CCNB2 O95067 1/20 0.30
CCNE2 O96020 1/20 0.30
CDK1 P06493 1/20 0.30
CCNB1 P14635 1/20 0.30
CCNE1 P24864 1/20 0.30
CDK2 P24941 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24251329 0.93 CDK4 (0.32) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL23438302 0.91 CDK4 (0.36) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL24251303 0.90 CDK4 (0.35) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL24251304 0.90 CDK4 (0.35) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL24251342 0.90 CDK4 (0.35) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL24251310 0.88 CDK4 (0.35) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL24251340 0.88 CDK4 (0.35) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL24251331 0.88 CDK4 (0.35) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL24251316 0.88 CDK4 (0.35) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL24251332 0.88 CDK4 (0.35) ESR1ESR2HSD17B1HSD17B2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220052263-A1 AMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD., (KR) 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220052263-A1 AMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AOC2, ODC1, AOC1 ESR1 204/4885ESR2 758/4885HSD17B1 2160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.